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The ubiquitin clan: A protein family essential for lifeWhen in 1978 biochemical experiments uncovered a heat stable
polypeptide component of an ATP-dependent proteolytic system
from reticulocytes, APF-1 [1], later identiﬁed as ubiquitin [2]
(a molecule previously discovered as ‘‘ubiquitous immunopoietic
polypeptide’’ [3]), nobody in the scientiﬁc community would have
imagined the impact this 76 amino acids containing molecule will
have more than 30 years later in our understanding of cellular reg-
ulation. The discovery of ubiquitin function evolved from the
search for, a long time enigmatic, energy-dependent degradation
process of individual cellular proteins. It was uncovered that
ubiquitin is covalently bound to proteins to subject them to prote-
olysis and that this process requires ATP [4]. An isopeptide linkage
is formed between the C-terminal glycin of ubiquitin and a lysine
residue of the protein [5]. In case lysine residues are missing also
binding of ubiquitin to the amino terminus of a protein can occur
[6]. Linking ubiquitin to a protein requires three steps: (i) the
C-terminal activation of ubiquitin via an ubiquitin-adenylate and
formation of an thioester, (ii) transfer of ubiquitin as thioester to
a ubiquitin conjugating enzyme E2 and (iii) the ﬁnal formation of
the isopeptide bond of ubiquitin with the protein together with
an ubiquitin ligase, E3 [7,8]. All the early studies on the ubiquitin
triggered proteolytic system had been carried out in a cell-free
system. The breakthrough, showing that the ubiquitin system is
indeed of tremendous physiological relevance, came from the
study of a mammalian mutant cell line conditionally defective in
the ubiquitin activating enzyme E1: This mutant exhibits a
disturbed cell cycle and a defective degradation of short-lived
intracellular proteins under restrictive conditions [9,10]. This
proved the invaluable tool of genetics to unravel the ubiquitin sys-
tem in its details and initiated genetic and molecular biological
experimentation on the best studied eukaryotic model organism,
the yeast Saccharomyces cerevisiae [11–13]. The protease ﬁnally
degrading the ubiquitin tagged proteins remained an enigma for
some time. As before, in cell-free extracts a high molecular mass
protein was found which was able to degrade ubiquitin tagged pro-
teins [14,15]. Again, yeast genetics uncovered that this proteinase,
called proteasome, is actually the machine required for degrada-
tion of ubiquitinated proteins in vivo [16]. At this time the term
ubiquitin-proteasome system (UPS) was coined. A multitude of
proteolytic processes involving the degradation of speciﬁc proteins
by the ubiquitin proteasome system was discovered soon thereaf-
ter: First reports concerned transcriptional regulation [17,18], cell
cycle progression [19,20], metabolic regulation [21,22] and protein
quality control of the endoplasmic reticulum (ERAD) [23]. Rapidly
thereafter, a multitude of proteins of different cellular pathways
were shown to be selectively degraded by the UPS (for review,
see [24]). Protein degradation by the UPS was shown not to depend
on many single ubiquitin molecules, linked to many different0014-5793/$36.00  2011 Federation of European Biochemical Societies. Published by E
doi:10.1016/j.febslet.2011.08.020lysine residues of the protein but on a polyubiquitin chain instead,
which is built up on the protein target utilizing one of the seven
lysine residues of ubiquitin itself, K48 [25]. Most interestingly, a
tetrameric ubiquitin chain unit increases the afﬁnity for the pro-
teasome by a factor of about 100 and represents a unique binding
determinant, that is not created by shorter chains and is also not
present in mono-ubiquitin [26]. Obviously it is the surface that
can be created by chain formation, which is recognized by different
receptors. The changing localization of the hydrophobic surface
patch with isoleucine 44 of ubiquitin through chain formation
obviously determines the binding properties. Taking into account
the seven lysine residues in ubiquitin (K6, K11, K27, K29, K33,
K48 and K63) as well as the N-terminus of methionine 1 and the
possibility of forming also mixed chains, one can imagine nature’s
potential to create a myriad of different surfaces which can be
decoded by different receptors (proteins with ubiquitin binding
domains, UBDs) all inducing different cellular responses (for
review see [27]). One may imagine that evolution has a fantastic
playground still here in the future. The presence of ubiquitin chain
elongating enzymes (E4 ligases) [28] (for review see [29]) and
many different de-ubiquitylating enzymes (DUBs) (for review see
[29,30]) might inﬂuence the dynamics of the different processes.
Recently also unconventional tagging of proteins with ubiquitin
utilizing serine/threonine and cysteine residues has been discov-
ered [31]. The K48 linked ubiquitin chains targeting proteins to
proteasomal destruction have been coined the ‘‘classical’’ or
‘‘canonical’’ ubiquitin chains. About 20 years after the discovery
of ubiquitin triggering protein degradation, it came as a surprise
when it was discovered that ubiquitin is also involved in non-
proteolytic processes. Here, non-classical (non-canonical) linkage
types formed by M1-, K11- or K63-linked ubiquitin chains were
found. Such non-proteolytic processes include DNA repair [32], cell
cycle progression, innate immunity and inﬂammation [27,33].
Interestingly, however, non-canonical polyubiquitin chains can
also be proteolysis signals. For instance, K11 chains generated by
the anaphase promoting complex or a mixture of K11, K48 and
K63 chains linked to cyclin B1 can be signals for proteasomal
degradation [27,34,35]. In addition, also mono-ubiquitination of
proteins has been shown to be an important signal: Multiple
mono-ubiquitins or oligo-ubiquitin chains serve as a sorting signal
on plasma membrane proteins for internalization into the endo-
cytic pathway [36]. Mono-ubiquitination is required for sorting
membrane embedded cargo proteins to the endosome and lyso-
some via the ESCRT pathway [37,38]. One of the future goals must
consist in a precise understanding of how the ubiquitin binding
partners (receptors) selectively decode the many different ubiqui-
tin signals presented on proteins in time and space and by this reg-
ulate the protein orchestra of the cell on the many different levels.lsevier B.V. All rights reserved.
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and its widespread cellular functions had provoked, the discovery
of protein modiﬁers of the ubiquitin type came as an additional
surprise. All newly discovered ubiquitin-like modiﬁers (UBLs)
share the typical b-grasp fold of ubiquitin. Conjugation of these
ubiquitin-like modiﬁers to proteins utilizes mechanistically similar
pathways as found for ubiquitin conjugation. In order to minimize
crosstalk with ubiquitin, the conjugation components, however,
are distinct. Yet discovered UBLs include ISG15, the SUMO family
(SUMO1, SUMO2, SUMO3; Smt3 in yeast), Urm1, NEDD8 (Rub1 in
yeast), FUBI (also known as MNSF-b or FAU), FAT10, UFM1, Atg8
and Atg12. Putative UBLs are BUBL1, BUBL2, UBL-1, SF3A120 and
oligoadenylate synthetase (for review, see [39,40]). In the follow-
ing some functions of the yet best studied UBLs are mentioned:
ISG15 was the ﬁrst UBL found [41]. The 15kD protein is strongly in-
duced by interferons and connected to antiviral responses [42].
SUMO conjugation to target proteins controls a widespread num-
ber of cellular activities. Among them are nuclear transport
[43,44], DNA repair [32], cell cycle progression or responses to viral
infections [39,45]. Most interestingly, the SUMO system and the
ubiquitin system perform crosstalks [32]. The fact that SUMO can
act as a signal for ubiquitination of poly-SUMO chain modiﬁed pro-
teins by extending the SUMO chain with an ubiquitin chain and
target these proteins for proteasomal degradation was surprising
[46] (for review see [47]). The creation of mixed SUMO-ubiquitin
chains expands even more the cell’s repertoire of signalling sur-
faces to speciﬁcally regulate protein activity. NEDD8 also crosstalks
to the ubiquitin system. Its conjugation regulates the activity of
cullin-family E3 ubiquitin ligases (for review see [48]).
FAT10, originally known as diubiquitin has turned out to be an
additional UBL, targeting proteins to the proteasome for degrada-
tion. Its induction by cytokines points to the fact that it may play
a speciﬁc role in the immune system [49] (for review see [50]).
Atg8 and Atg12 are UBLs, which provide the link to a different cel-
lular proteolytic pathway, autophagocytosis. Atg12 is conjugated to
the Atg5 protein and Atg8 is conjugated to the lipid phosphatidyl-
ethanolamine of themembrane of the forming autophagosome. Both
conjugation steps are essential for autophagy andﬁnally thedegrada-
tion of phagocytosed cellular material in the lysosome [51,52].
The extraordinary mechanistic impact of ubiquitin and the
many ubiquitin like proteins in cell regulation have posed the
question about ancestor proteins and their evolution. Modern
sequence comparison methods, structure determination and
mechanistic analysis of the biosynthesis of secondary metabolites
and cofactors in procaryotes have led the way. Obviously the
biochemical toolbox of the key sulfur incorporation steps in the
biosynthetic pathways for thiamine and molybdenum/tungsten
cofactors (MoCo/Wco) in bacteria has been evolved to the eukary-
otic ubiquitin family conjugation system [40,53]. As the highly
ﬂexible but controlled conjugation of the ubiquitin family proteins
to the orchestra of cellular proteins is central to most, if not all
physiological processes, it is not surprising that the list of diseases
connected to misregulation of the system is steadily growing.
Many cancers, severe types of mental retardation, protein folding
diseases leading to neurodegenerative disorders (Alzheimer dis-
ease, Parkinson disease, Huntingston disease, Creutzfeldt-Jakob
disease) or metabolic diseases as type 2 diabetes make the ubiqui-
tin family conjugation system a major target for mechanism based
drug intervention [54]. It must therefore be a major goal in the
future to understand the nearly universally employed ubiquitin
family conjugation system comprehensively.
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